Ribavirin can be mutagenic for arenaviruses.

Area of Science:

• Virology
• Antiviral Research
• Molecular Biology

Background:

• Arenaviruses pose significant threats to human health, with limited therapeutic options.
• Ribavirin is the sole antiviral treatment for arenavirus infections, but its mechanism remains unclear.

Purpose of the Study:

• To elucidate the antiviral mechanism of ribavirin against arenaviruses.
• To investigate if ribavirin induces mutations in the lymphocytic choriomeningitis virus (LCMV).

Main Methods:

• Cell culture experiments were performed using the prototypic arenavirus LCMV.
• Ribavirin's mutagenic effects were assessed under single- and multiple-passage conditions.
• The study ruled out decreased intracellular GTP pools via IMPDH inhibition as the cause of mutagenesis.

Main Results:

• Ribavirin demonstrated mutagenic activity against LCMV in cell culture.
• This mutagenic effect was observed across different passage regimes.
• The observed mutagenesis was independent of ribavirin's inhibition of inosine monophosphate dehydrogenase (IMPDH).

Conclusions:

• Ribavirin's antiviral activity against arenaviruses may stem from lethal mutagenesis.
• This finding offers potential new avenues for developing effective antiarenavirus therapies.